TP53 Gene Mutation: Clinical Trials

1 trial for TP53 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1

Follow TP53 Gene Mutation: new trials by email Literature Review of TP53 Gene Mutation trials Research Report on TP53 Gene Mutation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Allogeneic Hematopoietic Stem Cell Transplantation, Irradiated Allogeneic Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia in Remission
Early Phase 1TerminatedRutgers, The State University of New Jersey22020-10-262023-06-26

Narrower conditions

Chromosome 17 deletion (1)  ·  Hematologic Neoplasms (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm, Residual (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoproliferative Disorders (1)

Sponsors

Rutgers, The State University of New Jersey (1)

Countries

United States (1)

Top investigators

Roger Strair (1)

NIH funding

P30CA072720 (1)